Champions Oncology stock forecast
Want to see CSBR full AI Analyst Report?
Champions Oncology (CSBR) Stock Forecast & Price Target
CSBR Analyst Ratings
CSBR Stock 12 Month Forecast
Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Matt Hewitt | Craig-Hallum | $12 | buy | 151.05%Upside | Reiterated | 12/16/25 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Matt HewittCraig-Hallum | BuyReiterated$12 | 12/16/25 | 151.05%Upside |
Best Analysts Covering Champions Oncology
Copying Matt Hewitt's trades and holding each position for 3 Months would result in 25.00% of your transactions generating a profit, with an average return of -1.69% per trade.
Copying Matt Hewitt's trades and holding each position for 1 Year would result in 41.67% of your transactions generating a profit, with an average return of +4.75% per trade.
Copying Matt Hewitt's trades and holding each position for 2 Years would result in 41.67% of your transactions generating a profit, with an average return of -7.49% per trade.
CSBR Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, CSBR has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CSBR average Analyst price target in the past 3 months is ―.
CSBR Financial Forecast
CSBR Earnings Forecast
Next quarter’s earnings estimate for CSBR is $0.05 with a range of ― to ―. The previous quarter’s EPS was $0.05. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
CSBR Sales Forecast
Next quarter’s sales forecast for CSBR is $15.23M with a range of ― to ―. The previous quarter’s sales results were $15.23M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
